Literature DB >> 26835752

Parathyroid hormone, cardiovascular and all-cause mortality: A meta-analysis.

Bo Yang1, Changlin Lu2, Qing Wu3, Jian Zhang3, Hua Zhao3, Yukang Cao3.   

Abstract

BACKGROUND: Inconsistent findings have reported on parathyroid hormone (PTH) concentration and cardiovascular or all-cause mortality.
OBJECTIVE: To investigate whether elevated PTH concentration was an independent predictor for cardiovascular or all-cause mortality in the general population by conducting a meta-analysis based on prospective studies.
METHOD: We searched Cochrane Library, Pubmed, and Embase databases up to June 2015. Only prospective studies evaluating serum PTH concentration and cardiovascular or all-cause mortality were included. Pooled adjust risk ratio (RR) and corresponding 95% confidence intervals (CI) were calculated for the highest vs. lowest PTH concentration.
RESULTS: Ten studies with 31,616 subjects were identified and analyzed. Compared the highest to the lowest PTH concentration, elevated serum PTH concentration increased the risk of all-cause mortality (RR 1.19; 95% CI 1.08-1.30) but not for cardiovascular mortality (RR 1.26; 95% CI 0.96-1.66). Subgroup analyses indicated that cardiovascular mortality risk appeared to be more pronounced among men (RR 1.68; 95% CI 1.05-2.67).
CONCLUSIONS: Elevated PTH concentration is an independent predictor of all-cause mortality. Elevated serum PTH concentration appears to increase risk of cardiovascular mortality among men.
Copyright © 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  All-cause mortality; Cardiovascular mortality; Meta-analysis; Parathyroid hormone

Mesh:

Substances:

Year:  2016        PMID: 26835752     DOI: 10.1016/j.cca.2016.01.034

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  8 in total

Review 1.  How the reference values for serum parathyroid hormone concentration are (or should be) established?

Authors:  J-C Souberbielle; F Brazier; M-L Piketty; C Cormier; S Minisola; E Cavalier
Journal:  J Endocrinol Invest       Date:  2016-10-01       Impact factor: 4.256

2.  Parathyroid hormone and risk of heart failure in the general population: A meta-analysis of prospective studies.

Authors:  Fanbo Meng; Wei Wang; Jianghong Ma; Baisong Lin
Journal:  Medicine (Baltimore)       Date:  2016-10       Impact factor: 1.889

3.  Associations of fibroblast growth factor 23, vitamin D and parathyroid hormone with 5-year outcomes in a prospective primary care cohort of people with chronic kidney disease stage 3.

Authors:  Adam Shardlow; Natasha J McIntyre; Richard J Fluck; Christopher W McIntyre; Maarten W Taal
Journal:  BMJ Open       Date:  2017-08-23       Impact factor: 2.692

4.  Longitudinal Assessment of PTH in Community-Dwelling Older Women-Elevations Are Not Associated With Mortality.

Authors:  David Buchebner; Linnea Malmgren; Anders Christensson; Fiona McGuigan; Paul Gerdhem; Martin Ridderstråle; Kristina Åkesson
Journal:  J Endocr Soc       Date:  2017-04-19

5.  Racial/Ethnic Differences in 25-Hydroxy Vitamin D and Parathyroid Hormone Levels and Cardiovascular Disease Risk Among Postmenopausal Women.

Authors:  Xi Zhang; Wanzhu Tu; JoAnn E Manson; Lesley Tinker; Simin Liu; Jane A Cauley; Lihong Qi; Charles Mouton; Lisa W Martin; Lifang Hou; Yiqing Song
Journal:  J Am Heart Assoc       Date:  2019-02-19       Impact factor: 5.501

6.  Serum phosphate levels are related to all-cause, cardiovascular and COPD mortality in men.

Authors:  Natalia Campos-Obando; Lies Lahousse; Guy Brusselle; Bruno H Stricker; Albert Hofman; Oscar H Franco; André G Uitterlinden; M Carola Zillikens
Journal:  Eur J Epidemiol       Date:  2018-05-15       Impact factor: 8.082

7.  Parathormone Levels in a Middle-Eastern Healthy Population Using 2nd and 3rd Generation PTH Assays.

Authors:  Marie-Hélène Gannagé-Yared; Marie-Noëlle Kallas-Chémaly; Ghassan Sleilaty
Journal:  Int J Endocrinol       Date:  2020-02-21       Impact factor: 3.257

8.  Effects of parathyroidectomy on plasma PTH fragments and heart rate variability in stage 5 chronic kidney disease patients.

Authors:  Huimin Chen; Wenkai Ren; Zhanhui Gao; Ming Zeng; Shaowen Tang; Fangyan Xu; Yaoyu Huang; Lina Zhang; Ying Cui; Guang Yang; Hanyang Qian; Wenbin Zhou; Chun Ouyang; Xueyan Gao; Jing Zhang; Yujie Xiao; Baiqiao Zhao; Jing Wang; Anning Bian; Fan Li; Huiting Wan; Wei Gao; Xiaoyun Wang; Changying Xing; Xiaoming Zha; Ningning Wang
Journal:  Ren Fail       Date:  2021-12       Impact factor: 2.606

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.